UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC  20549

FORM 10-Q
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:
March 31, 2023
  

OR

☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from
to
  
Commission file number: 001-07626

Sensient Technologies Corporation
(Exact name of registrant as specified in its charter)

Wisconsin
  
39-0561070
(State or other jurisdiction of incorporation or organization)
  
(I.R.S. Employer Identification Number)

777 EAST WISCONSIN AVENUE, MILWAUKEE, WISCONSIN 53202-5304
(Address of principal executive offices)

Registrant’s telephone number, including area code:
(414) 271-6755

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.10 per share
SXT
New York Stock Exchange LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days.Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer   ☒
Accelerated Filer ☐
Non-Accelerated Filer ☐
     
Smaller Reporting Company ☐
Emerging Growth Company ☐
  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐    No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class
  
Outstanding at April 26, 2023
Common Stock, par value $0.10 per share
  
42,244,371

SENSIENT TECHNOLOGIES CORPORATION
INDEX

     
Page No.
       
PART I. FINANCIAL INFORMATION:
  
       
 
Item 1.
Financial Statements:
  
       
   
1
       
   
2
       
   
3
       
   
4
       
   
5
       
   
6
       
 
Item 2.
11
       
 
Item 3.
14
       
 
Item 4.
14
       
PART II. OTHER INFORMATION:
  
       
 
Item 1.
15
       
 
Item 1A.
15
       
 
Item 2.
15
       
 
Item 6.
15
       
   
16
       
    17

PART I.
FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS

SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED STATEMENTS OF EARNINGS
(In thousands except per share amounts)
(Unaudited)

 
Three Months
Ended March 31,
  
             
   
2023
    
2022
  
             
Revenue
  
$
369,006
    
$
355,521
  
Cost of products sold
    
244,343
      
230,675
  
Selling and administrative expenses
    
73,825
      
72,057
  
Operating income
    
50,838
      
52,789
  
Interest expense
    
6,002
      
2,993
  
Earnings before income taxes
    
44,836
      
49,796
  
Income taxes
    
11,185
      
12,725
  
Net earnings
  
$
33,651
    
$
37,071
  
                 
Weighted average number of common shares outstanding:
                
Basic
    
41,970
      
41,865
  
Diluted
    
42,255
      
42,148
  
                 
Earnings per common share:
                
Basic
  
$
0.80
    
$
0.89
  
Diluted
  
$
0.80
    
$
0.88
  
                 
Dividends declared per common share
  
$
0.41
    
$
0.41
  

See accompanying notes to consolidated condensed financial statements.

1
Index
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)

 
Three Months
Ended March 31,
  
   
2023
    
2022
  
             
Comprehensive income
  
$
49,952
    
$
36,834
  

See accompanying notes to consolidated condensed financial statements.

2
Index
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands)


  
March 31,
2023
(Unaudited)
    
December 31,
2022
  
Assets
           
Current Assets:
            
Cash and cash equivalents
  
$
24,017
    
$
20,921
  
Trade accounts receivable
    
312,530
      
302,109
  
Inventories
    
573,706
      
564,110
  
Prepaid expenses and other current assets
    
49,639
      
47,640
  
                 
Total current assets
    
959,892
      
934,780
  
                 
Other assets
    
96,077
      
96,609
  
Deferred tax assets
    
35,108
      
32,717
  
Intangible assets, net
    
18,569
      
18,600
  
Goodwill
    
419,302
      
415,715
  
Property, Plant, and Equipment:
                
Land
    
31,734
      
31,444
  
Buildings
    
325,796
      
322,268
  
Machinery and equipment
    
738,524
      
722,294
  
Construction in progress
    
73,502
      
65,809
  
     
1,169,556
      
1,141,815
  
Less accumulated depreciation
    
(675,777
)
    
(658,622
)
     
493,779
      
483,193
  
                 
Total assets
  
$
2,022,727
    
$
1,981,614
  
                 
Liabilities and Shareholders’ Equity
                
                 
Current Liabilities:
                
Trade accounts payable
  
$
121,290
    
$
142,365
  
Accrued salaries, wages, and withholdings from employees
    
22,788
      
43,738
  
Other accrued expenses
    
48,789
      
51,231
  
Income taxes
    
16,935
      
14,446
  
Short-term borrowings
    
24,849
      
20,373
  
                 
Total current liabilities
    
234,651
      
272,153
  
                 
Deferred tax liabilities
    
16,200
      
15,977
  
Other liabilities
    
36,652
      
37,191
  
Accrued employee and retiree benefits
    
27,224
      
26,364
  
Long-term debt
    
679,779
      
630,331
  
Shareholders’ Equity:
                
Common stock
    
5,396
      
5,396
  
Additional paid-in capital
    
112,589
      
124,043
  
Earnings reinvested in the business
    
1,719,096
      
1,702,700
  
Treasury stock, at cost
    
(624,473
)
    
(631,853
)
Accumulated other comprehensive loss
    
(184,387
)
    
(200,688
)
                 
Total shareholders’ equity
    
1,028,221
      
999,598
  
                 
Total liabilities and shareholders’ equity
  
$
2,022,727
    
$
1,981,614
  

See accompanying notes to consolidated condensed financial statements.

3
Index
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 
Three Months
Ended March 31,
  
   
2023
    
2022
  
             
Cash flows from operating activities:
            
Net earnings
  
$
33,651
    
$
37,071
  
Adjustments to arrive at net cash provided by operating activities:
                
Depreciation and amortization
    
14,150
      
13,056
  
Share-based compensation expense
    
2,267
      
4,163
  
Net loss (gain) on assets
    
8
      
(48
)
Deferred income taxes
    
(2,351
)
    
4,211
  
Changes in operating assets and liabilities:
                
Trade accounts receivable
    
(7,142
)
    
(20,841
)
Inventories
    
(4,374
)
    
(11,901
)
Prepaid expenses and other assets
    
(2,062
)
    
(11,111
)
Accounts payable and other accrued expenses
    
(19,251
)
    
(10,267
)
Accrued salaries, wages, and withholdings from employees
    
(21,187
)
    
(12,425
)
Income taxes
    
2,548
      
7,063
  
Other liabilities
    
698
      
137
  
                 
Net cash used in operating activities
    
(3,045
)
    
(892
)
                 
Cash flows from investing activities:
                
Acquisition of property, plant, and equipment
    
(22,278
)
    
(12,736
)
Proceeds from sale of assets
    
1
      
89
  
Other investing activities
    
(602
)
    
434
  
                 
Net cash used in investing activities
    
(22,879
)
    
(12,213
)
                 
Cash flows from financing activities:
                
Proceeds from additional borrowings
    
50,827
      
40,099
  
Debt payments
    
(1,351
)
    
(6,275
)
Dividends paid
    
(17,255
)
    
(17,211
)
Other financing activities
    
(7,669
)
    
(1,679
)
                 
Net cash provided by financing activities
    
24,552
      
14,934
  
                 
Effect of exchange rate changes on cash and cash equivalents
    
4,468
      
4,606
  
                 
Net increase in cash and cash equivalents
    
3,096
      
6,435
  
Cash and cash equivalents at beginning of period
    
20,921
      
25,740
  
Cash and cash equivalents at end of period
  
$
24,017
    
$
32,175
  

See accompanying notes to consolidated condensed financial statements.

4
Index
SENSIENT TECHNOLOGIES CORPORATION
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(In thousands, except share and per share amounts)
(Unaudited)

 
Common
    
Additional
Paid-In
    
Earnings
Reinvested
in the
    
Treasury Stock
    
Accumulated
Other
Comprehensive
    
Total
  
Three Months Ended March 31, 2023
  
Stock
    
Capital
    
Business
    
Shares
    
Amount
    
Income (Loss)
    
Equity
  
Balances at December 31, 2022
  
$
5,396
    
$
124,043
    
$
1,702,700
      
12,058,773
    
$
(631,853
)
  
$
(200,688
)
  
$
999,598
  
Net earnings
    
-
      
-
      
33,651
      
-
      
-
      
-
      
33,651
  
Other comprehensive income
    
-
      
-
      
-
      
-
      
-
      
16,301
   
16,301
Cash dividends paid – $0.41 per share
    
-
      
-
      
(17,255
)
    
-
      
-
      
-
      
(17,255
)
Share-based compensation
    
-
      
2,267
      
-
      
-
      
-
      
-
      
2,267
  
Non-vested stock issued upon vesting
    
-
      
(11,956
)
    
-
      
(228,181
)
    
11,956
      
-
      
-
  
Benefit plans
     -       375       -       (18,172 )     952       -       1,327  
Other
    
-
      
(2,140
)
    
-
      
105,524
      
(5,528
)
    
-
      
(7,668
)
Balances at March 31, 2023
  
$
5,396
    
$
112,589
    
$
1,719,096
      
11,917,944
    
$
(624,473
)
  
$
(184,387
)
  
$
1,028,221
  

Three Months Ended March 31, 2022
                                          
Balances at December 31, 2021
   $ 5,396     $ 111,352     $ 1,630,713       12,107,549     $ (634,408 )   $ (174,628 )   $ 938,425  
Net earnings
     -       -       37,071       -       -       -       37,071  
Other comprehensive loss
     -       -       -       -       -       (237 )     (237 )
Cash dividends paid – $0.41 per share
     -       -       (17,211 )     -       -       -       (17,211 )
Share-based compensation
     -       4,163       -       -       -       -       4,163  
Non-vested stock issued upon vesting
     -       (2,478 )     -       (47,298 )     2,478       -       -  
Benefit plans
     -       560       -       (11,786 )     618       -       1,178  
Other
     -
       (624 )     15       20,403       (1,070 )     -       (1,679 )
Balances at March 31, 2022
   $ 5,396     $ 112,973     $ 1,650,588       12,068,868     $ (632,382 )   $ (174,865 )   $ 961,710  

See accompanying notes to consolidated condensed financial statements.
5
Index
SENSIENT TECHNOLOGIES CORPORATION
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(Unaudited)
1.
Accounting Policies

In the opinion of Sensient Technologies Corporation (the Company), the accompanying unaudited consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) that are necessary to present fairly the financial position of the Company as of March 31, 2023, and the results of operations, comprehensive income, cash flows, and shareholders’ equity for the three months ended March 31, 2023 and 2022. The results of operations for any interim period are not necessarily indicative of the results to be expected for the full year.

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Expenses are charged to operations in the period incurred.

Please refer to the notes in the Company’s annual consolidated financial statements for the year ended December 31, 2022, for additional details of the Company’s financial condition and a description of the Company’s accounting policies, which have been continued without change.

2.
Acquisition

On October 3, 2022, the Company acquired Endemix Doğal Maddeler A.Ş. and Teknoloji Yatırımları ve Danışmanlık Sanayi ve Ticaret A.Ş. (collectively, Endemix), a natural colors business located in Turkey. The Company paid $23.3 million in cash for this acquisition, which is net of $1.3 million in debt assumed, with $1.7 million of such amount being held back by the Company for 12 months to satisfy any indemnification claims that may arise. The assets acquired and liabilities assumed were recorded at their estimated fair value as of the acquisition date. The Company acquired net assets of $8.9 million and identified intangible assets, principally technological know-how and customer relationships, of $4.9 million. The remaining $9.5 million was allocated to goodwill. The Company is still in the process of finalizing the estimated values for identifiable intangible assets and fixed assets. The Company will complete this analysis in 2023. This business is part of the Color segment.

3.
Trade Accounts Receivable

Trade accounts receivables are recorded at their face amount, less an allowance for expected losses on doubtful accounts. The allowance for doubtful accounts is calculated based on customer-specific analysis and an aging methodology using historical loss information. The Company believes historical loss information is a reasonable basis for expected credit losses as the Company’s historical credit loss experience correlates with its customer delinquency status. This information is also adjusted for any known current economic conditions. Forecasted economic conditions have not had a significant impact on the current credit loss estimate due to the short-term nature of the Company’s customer receivables; however, the Company will continue to monitor and evaluate the rapidly changing economic conditions. Additionally, as the Company only has one portfolio segment, there are not different risks between portfolios. Specific accounts are written off against the allowance for doubtful accounts when the receivable is deemed no longer collectible.
6
Index
The following table summarizes the changes in the allowance for doubtful accounts during the three month periods ended March 31, 2023 and 2022:

(In thousands)
Three Months Ended March 31, 2023
  
Allowance for
Doubtful Accounts
  
Balance at December 31, 2022
  
$
4,436
  
Provision for expected credit losses
    
120
  
Accounts written off
    
(614
)
Translation and other activity
    
103
  
Balance at March 31, 2023
  
$
4,045
  

(In thousands)
Three Months Ended March 31, 2022
  
Allowance for
Doubtful Accounts
  
Balance at December 31, 2021
  
$
4,877
  
Provision for expected credit losses
    
285
  
Accounts written off
    
(367
)
Translation and other activity
    
117
Balance at March 31, 2022
  
$
4,912
  


7
Index
4.
Inventories
 
At March 31, 2023, and December 31, 2022, inventories included finished and in-process products totaling $372.6 million and $385.2 million, respectively, and raw materials and supplies of $201.1 million and $178.9 million, respectively.

5.
Fair Value

Accounting Standards Codification 820, Fair Value Measurement, defines fair value for financial assets and liabilities, establishes a framework for measuring fair value in GAAP, and expands disclosures about fair value measurements. The carrying values of the Company’s cash and cash equivalents, trade accounts receivable, trade accounts payable, accrued expenses, and short-term borrowings were approximately the same as the fair values as of March 31, 2023 and December 31, 2022. The net fair value of the forward exchange contracts based on current pricing obtained for comparable derivative products (Level 2 inputs) was an asset of $1.2 million and a liability of $0.2 million as of March 31, 2023 and December 31, 2022, respectively. The fair value of the Company’s long-term debt, including current maturities, is estimated using discounted cash flows based on the Company’s current incremental borrowing rates for similar types of borrowing arrangements (Level 2 inputs). The carrying value of the long-term debt at March 31, 2023 and December 31, 2022, was $680.2 million and $630.8 million, respectively. The fair value of the long-term debt at March 31, 2023 and December 31, 2022, was $672.5 million and $622.2 million, respectively.


6.
Segment Information

The Company evaluates performance based on operating income before share-based compensation, interest expense, and income taxes (segment operating income). Total revenue and segment operating income by business segment and geographic region include both sales to customers, as reported in the Company’s Consolidated Statements of Earnings, and intersegment sales, which are accounted for at prices that approximate market prices and are eliminated in consolidation.

The Company determines its operating segments based on information utilized by its chief operating decision maker to allocate resources and assess performance. The Company’s three reportable segments are the Flavors & Extracts and Color segments, which are both managed on a product line basis, and the Asia Pacific segment, which is managed on a geographic basis. The Company’s Flavors & Extracts segment produces flavor, extracts, and essential oils products that impart a desired taste, texture, aroma, or other characteristics to a broad range of consumer and other products. The Color segment produces natural and synthetic color systems for use in foods, beverages, pharmaceuticals, and nutraceuticals; colors and other ingredients for personal care, such as active ingredients, solubilizers, and surface treated pigments; pharmaceutical and nutraceutical excipients, such as colors, flavors, coatings, and nutraceutical ingredients; and technical colors for industrial applications. The Asia Pacific segment is managed on a geographic basis and produces and distributes color, flavor, and essential oils products in the Asia Pacific countries. The Company’s corporate expenses and share-based compensation are included in the “Corporate & Other” category.

Operating results by segment for the periods presented are as follows:

(In thousands)
  
Flavors &
Extracts
    
Color
    
Asia
Pacific
    
Corporate &
Other
    
Consolidated
  
Three months ended March 31, 2023:
                              
Revenue from external customers
  
$
171,972
    
$
156,949
    
$
40,085
    
$
-
    
$
369,006
  
Intersegment revenue
    
6,880
      
4,212
      
-
      
-
      
11,092
  
Total revenue
  
$
178,852
    
$
161,161
    
$
40,085
    
$
-
    
$
380,098
  
                                         
Operating income (loss)
  
$
22,180
    
$
31,885
    
$
9,241
    
$
(12,468
)
  
$
50,838
  
Interest expense
    
-
      
-
      
-
      
6,002
      
6,002
  
Earnings (loss) before income taxes
  
$
22,180
    
$
31,885
    
$
9,241
    
$
(18,470
)
  
$
44,836
  
                                         
Three months ended March 31, 2022:
                                        
Revenue from external customers
  
$
175,202
    
$
143,928
    
$
36,391
    
$
-
    
$
355,521
  
Intersegment revenue
    
7,525
      
4,510
      
74
      
-
      
12,109
  
Total revenue
  
$
182,727
    
$
148,438
    
$
36,465
    
$
-
    
$
367,630
  
                                         
Operating income (loss)
  
$
27,579
    
$
30,657
    
$
8,204
    
$
(13,651
)
  
$
52,789
  
Interest expense
    
-
      
-
      
-
      
2,993
      
2,993
  
Earnings (loss) before income taxes
  
$
27,579
    
$
30,657
    
$
8,204
    
$
(16,644
)
  
$
49,796
  

Product Lines

(In thousands)
  
Flavors &
Extracts
    
Color
    
Asia Pacific
    
Consolidated
  
Three months ended March 31, 2023:
                        
Flavors, Extracts & Flavor Ingredients
  
$
124,825
    
$
-
    
$
-
    
$
124,825
  
Natural Ingredients
    
54,027
      
-
      
-
      
54,027
  
Food & Pharmaceutical Colors
    
-
      
118,747
      
-
      
118,747
  
Personal Care
    
-
      
42,414
      
-
      
42,414
  
Asia Pacific
    
-
      
-
      
40,085
      
40,085
  
Intersegment Revenue
    
(6,880
)
    
(4,212
)
    
-
   
(11,092
)
Total revenue from external customers
  
$
171,972
    
$
156,949
    
$
40,085
    
$
369,006
  
                                 
Three months ended March 31, 2022:
                                
Flavors, Extracts & Flavor Ingredients
  
$
126,518
    
$
-
    
$
-
    
$
126,518
  
Natural Ingredients
    
56,209
      
-
      
-
      
56,209
  
Food & Pharmaceutical Colors
    
-
      
103,109
      
-
      
103,109
  
Personal Care
    
-
      
44,846
      
-
      
44,846
  
Inks
    
-
      
483
      
-
      
483
  
Asia Pacific
    
-
      
-
      
36,465
      
36,465
  
Intersegment Revenue
    
(7,525
)
    
(4,510
)
    
(74
)
    
(12,109
)
Total revenue from external customers
  
$
175,202
    
$
143,928
    
$
36,391
    
$
355,521
  
8
Index
Geographic Markets

(In thousands)
  
Flavors &
Extracts
    
Color
    
Asia Pacific
    
Consolidated
  
Three months ended March 31, 2023:
                        
North America
  
$
131,968
    
$
78,377
    
$
62
    
$
210,407
  
Europe
    
28,927
      
43,252
      
103
      
72,282
  
Asia Pacific
    
5,201
      
18,149
      
39,195
      
62,545
  
Other
    
5,876
      
17,171
      
725
      
23,772
  
Total revenue from external customers
  
$
171,972
    
$
156,949
    
$
40,085
    
$
369,006
  
                                 
Three months ended March 31, 2022:
                                
North America
  
$
126,702
    
$
69,928
    
$
58
    
$
196,688
  
Europe
    
32,605
      
41,978
      
81
      
74,664
  
Asia Pacific
    
9,737
      
16,016
      
33,982
      
59,735
  
Other
    
6,158
      
16,006
      
2,270
      
24,434
  
Total revenue from external customers
  
$
175,202
    
$
143,928
    
$
36,391
    
$
355,521
  

7.
Retirement Plans

The Company’s components of annual benefit cost for the defined benefit plans for the periods presented are as follows:


 
Three Months Ended
March 31,
  
(In thousands)
  
2023
    
2022
  
Service cost
  
$
368
    
$
408
  
Interest cost
     409       244  
Expected return on plan assets
    
(239
)
    
(205
)
Recognized actuarial (gain) loss
     (139 )     12  
Total defined benefit expense
  
$
399
    
$
459
  

The Company’s non-service cost portion of defined benefit expense is recorded in Interest Expense on the Company’s Consolidated Statements of Earnings. The Company’s service cost portion of defined benefit expense is recorded in Selling and Administrative Expenses on the Company’s Consolidated Statements of Earnings.

8.
Derivative Instruments and Hedging Activity

The Company may use forward exchange contracts and foreign currency denominated debt to manage its exposure to foreign exchange risk in order to reduce the effect of fluctuating foreign currencies on short-term foreign currency denominated intercompany transactions, non-functional currency raw material purchases, non-functional currency sales, and other known foreign currency exposures. These forward exchange contracts generally have maturities of less than 18 months. The Company’s primary hedging activities and their accounting treatment are summarized below.

Forward exchange contracts – Certain forward exchange contracts have been designated as cash flow hedges. The Company had $55.5 million and $70.1 million of forward exchange contracts designated as cash flow hedges outstanding as of March 31, 2023 and December 31, 2022, respectively. For the three months ended March 31, 2023 and 2022, the amounts reclassified into net earnings in the Company’s Consolidated Statements of Earnings that offset the underlying transactions’ impact on earnings in the same period were not material. In addition, the Company utilizes forward exchange contracts that are not designated as cash flow hedges. The results of these transactions were not material to the financial statements.

Net investment hedges – The Company has designated certain foreign currency denominated long-term borrowings as partial hedges of the Company’s foreign currency net asset positions. As of March 31, 2023 and December 31, 2022, the total value of the Company’s net investment hedges was $319.9 million and $315.5 million, respectively. These net investment hedges included Euro and British Pound denominated long-term debt. Changes in the fair value of this debt attributable to changes in the spot foreign exchange rate are recorded in foreign currency translation in Other Comprehensive Income (OCI). For the three months ended March 31, 2023 and 2022, the impact of foreign exchange rates on these debt instruments increased debt by $4.4 million and decreased debt by $7.9 million, respectively, which has been recorded as foreign currency translation in OCI.

9
Index
9.
Income Taxes

The effective income tax rates for the three months ended March 31, 2023 and 2022, were 24.9% and 25.6%, respectively. The effective tax rates for the three months ended March 31, 2023 and 2022 were both impacted by changes in estimates associated with the finalization of prior year foreign tax items and the mix of foreign earnings.

10.
Accumulated Other Comprehensive Income

The following table summarizes the changes in OCI during the three month periods ended March 31, 2023 and 2022:

(In thousands)
  
Cash Flow
Hedges (1)
    
Pension
Items (1)
    
Foreign
Currency
Items
    
Total
  
Balances at December 31, 2022
  
$
(599
)
  
$
(1,792
)
  
$
(198,297
)
  
$
(200,688
)
Other comprehensive income before reclassifications
    
1,700
      
-
      
14,841
      
16,541
  
Amounts reclassified from OCI
    
(118
)
    
(122
)
    
-
      
(240
)
Balances at March 31, 2023
  
$
983
    
$
(1,914
)
  
$
(183,456
)
  
$
(184,387
)

(In thousands)
  
Cash Flow
Hedges (1)
    
Pension
Items (1)
    
Foreign
Currency
Items
    
Total
  
Balances at December 31, 2021
  
$
206
    
$
(353
)
  
$
(174,481
)
  
$
(174,628
)
Other comprehensive income (loss) before reclassifications
    
242
      
-
      
(145
)
    
97
Amounts reclassified from OCI
    
(342
)
    
8
      
-
      
(334
)
Balances at March 31, 2022
  
$
106
    
$
(345
)
  
$
(174,626
)
  
$
(174,865
)


(1)
Cash Flow Hedges and Pension Items are net of tax.

11.
Commitments and Contingencies


The Company is subject to various claims and litigation arising in the normal course of business. The Company establishes reserves for claims and proceedings when it is probable that liabilities exist and reasonable estimates of loss can be made. While it is not possible to predict the outcome of these matters, based on our assessment of the facts and circumstances now known, we do not believe that these matters, individually or in the aggregate, will have a material adverse effect on our financial position. However, actual outcomes may be different from those expected and could have a material effect on our results of operations or cash flows in a particular period.

12.
Subsequent Event

On April 27, 2023, the Company announced its quarterly dividend of $0.41 per share would be payable on June 1, 2023.

10
Index
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that reflect management’s current assumptions and estimates of future economic circumstances, industry conditions, Company performance, and financial results. Forward-looking statements include statements in the future tense, statements referring to any period after March 31, 2023, and statements including the terms “expect,” “believe,” “anticipate,” and other similar terms that express expectations as to future events or conditions. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for such forward-looking statements. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that could cause actual events to differ materially from those expressed in the forward-looking statements. A variety of factors could cause the Company’s actual results and experience to differ materially from the anticipated results. These factors and assumptions include, among others, the Company’s ability to manage economic and capital market conditions and the impact of recessions and economic downturns; the impact of macroeconomic and geopolitical volatility, including inflation and shortages impacting the availability and cost of raw materials, energy, and other supplies; the availability and cost of labor, logistics, and transportation; the impact and uncertainty created by the COVID-19 pandemic and efforts to manage it on the global economy, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, governmental regulations and restrictions, and general economic conditions; the uncertain impacts of the ongoing conflict between Russia and Ukraine on our supply chain, input costs, including energy and transportation, and on general economic conditions; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and operational improvement plan; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; currency exchange rate fluctuations; and the matters discussed under Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Except to the extent required by applicable law, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized.

OVERVIEW

Revenue
Revenue was $369.0 million and $355.5 million for the three months ended March 31, 2023 and 2022, respectively.  The increase in revenue was primarily due to favorable pricing, partially offset by lower volumes. For the three months ended March 31, 2023, the impact of foreign exchange rates decreased consolidated revenue by approximately 1%.

Gross Margin
The Company’s gross margin was 33.8% and 35.1% for the three months ended March 31, 2023 and 2022, respectively. The decrease in gross margin was primarily due to higher input costs and lower volumes, partially offset by an increase in pricing.

Selling and Administrative Expenses
Selling and administrative expense as a percent of revenue was 20.0% and 20.3% for the three months ended March 31, 2023 and 2022, respectively. The decrease in selling and administrative expenses as a percent of revenue was primarily due to lower performance-based executive compensation recorded in Corporate & Other.

Operating Income
Operating income was $50.8 million and $52.8 million for the three months ended March 31, 2023 and 2022, respectively. Operating margins were 13.8% and 14.8% for the three months ended March 31, 2023 and 2022, respectively. The decrease in operating margin is primarily due to higher input costs and lower volumes, partially offset by an increase in pricing.

Interest Expense
Interest expense was $6.0 million and $3.0 million for the three months ended March 31, 2023 and 2022, respectively. The increase in expense was primarily due to an increase in the average interest rate and the average debt outstanding.

11
Index
Income Taxes
The effective income tax rates for the three months ended March 31, 2023 and 2022 were 24.9% and 25.6%, respectively. The effective tax rates for the three months ended March 31, 2023 and 2022 were both impacted by changes in estimates associated with the finalization of prior year foreign tax items and the mix of foreign earnings.

Acquisition
On October 3, 2022, the Company acquired Endemix Doğal Maddeler A.Ş. and Teknoloji Yatırımları ve Danışmanlık Sanayi ve Ticaret A.Ş. (collectively, Endemix), a natural colors business located in Turkey. The Company paid $23.3 million in cash for this acquisition, which is net of $1.3 million in debt assumed, with $1.7 million of such amount being held back by the Company for 12 months to satisfy any indemnification claims that may arise. This business is part of the Color segment.

NON-GAAP FINANCIAL MEASURES

Within the following table, the Company reports certain non-GAAP financial measures, including: percentage changes in revenue, operating income, and diluted earnings per share on a local currency basis, which eliminate the effects that result from translating its international operations into U.S. dollars.

The Company has included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable year-over-year performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this report. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends, and the Company believes the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies.

The following table summarizes the percentage change for the results of the three months ended March 31, 2023, compared to the results for the three months ended March 31, 2022, in the respective financial measures.

 
Three Months Ended March 31, 2023
Revenue
Total
Foreign
Exchange
Rates
Local Currency
Flavors & Extracts
(2.1%)
(0.8%)
 (1.3%)
Color
8.6%
(1.4%)
10.0%
Asia Pacific
9.9%
(4.7%)
14.6%
Total Revenue
3.8%
(1.4%)
  5.2%
 
      
Operating Income
      
Flavors & Extracts
(19.6%)
(0.1%)
(19.5%)
Color
  4.0%
(2.3%)
  6.3%
Asia Pacific
12.6%
(5.4%)
18.0%
Corporate & Other
(8.7%)
(0.1%)
  (8.6%)
Total Operating Income
(3.7%)
(2.2%)
 (1.5%)
Diluted Earnings per Share
(9.1%)
(2.3%)
(6.8%)

SEGMENT INFORMATION

The Company determines its operating segments based on information utilized by its chief operating decision maker to allocate resources and assess performance. Segment performance is evaluated on operating income before share-based compensation and other costs (which are reported in Corporate & Other), interest expense, and income taxes.

The Company’s reportable segments consist of the Flavors & Extracts, Color, and Asia Pacific segments.

12
Index
Flavors & Extracts
Flavors & Extracts segment revenue was $178.9 million and $182.7 million for the three months ended March 31, 2023 and 2022, respectively, a decrease of approximately 2%. The decrease was a result of lower revenue in Flavors, Extracts & Flavor Ingredients and Natural Ingredients, primarily due to lower volumes, partially offset by higher selling prices. Flavors, Extracts & Flavor Ingredients was also unfavorably impacted by foreign exchange rates, which decreased segment revenue by approximately 1%.

Flavors & Extracts segment operating income was $22.2 million and $27.6 million for the three months ended March 31, 2023 and 2022, respectively, a decrease of approximately 20%. The lower segment operating income was a result of lower operating income in Flavors, Extracts & Flavor Ingredients and Natural Ingredients. The lower operating income in Flavors, Extracts & Flavor Ingredients was primarily due to higher raw material costs, lower volumes, and higher manufacturing and other costs, partially offset by higher selling prices and a favorable product mix. The lower operating income in Natural Ingredients was primarily due to higher raw material costs, lower volumes, and an unfavorable product mix, partially offset by higher selling prices and lower manufacturing and other costs. Foreign exchange rates had an immaterial impact on segment operating income. Segment operating income as a percent of revenue was 12.4% in the current quarter compared to 15.1% in the prior year’s comparable quarter.

Color
Segment revenue for the Color segment was $161.2 million and $148.4 million for the three months ended March 31, 2023 and 2022, respectively, an increase of approximately 9%. The increase was primarily a result of higher revenue in Food & Pharmaceutical Colors, partially offset by lower revenue in Personal Care.  The increase in Food & Pharmaceutical Colors was primarily due to higher selling prices and volumes and the acquisition of Endemix in October 2022, partially offset by the unfavorable impact of foreign exchange rates.  The decrease in Personal Care was primarily due to lower volumes and the unfavorable impact of foreign exchange rates, partially offset by higher selling prices. Foreign exchange rates decreased segment revenue by approximately 1%.

Segment operating income for the Color segment was $31.9 million and $30.7 million for the three months ended March 31, 2023 and 2022, respectively, an increase of approximately 4%. The increase in segment operating income was primarily a result of higher segment operating income in Food & Pharmaceutical Colors, partially offset by lower segment operating income in Personal Care. The higher operating income in Food & Pharmaceutical Colors was due to higher selling prices and volumes, partially offset by higher raw material costs, an unfavorable product mix, and higher manufacturing and other costs. The lower operating income in Personal Care was due to higher raw material costs, higher manufacturing and other costs, and lower volumes, partially offset by higher selling prices. Foreign exchange rates decreased segment operating income by approximately 2%. Segment operating income as a percent of revenue was 19.8% in the current quarter and 20.7% in the prior year’s comparable quarter.

Asia Pacific
Segment revenue for the Asia Pacific segment was $40.1 million and $36.5 million for the three months ended March 31, 2023 and 2022, respectively, an increase of approximately 10%. The increase was a result of higher volumes and selling prices, partially offset by the unfavorable impact of foreign exchange rates that decreased segment revenue by approximately 5%.

Segment operating income for the Asia Pacific segment was $9.2 million and $8.2 million for the three months ended March 31, 2023 and 2022, respectively, an increase of approximately 13%. The increase was primarily a result of higher selling prices and volumes, partially offset by higher raw material costs and manufacturing and other costs. Foreign exchange rates decreased segment operating income by approximately 5%. Segment operating income as a percent of revenue was 23.1% in the current quarter and 22.5% in the prior year’s comparable quarter.

Corporate & Other
The Corporate & Other operating expense was $12.5 million and $13.7 million for the three months ended March 31, 2023 and 2022, respectively. The decrease was primarily a result of a decrease in performance-based executive compensation.

LIQUIDITY AND FINANCIAL CONDITION

Financial Condition
The Company’s financial position remains strong. The Company is in compliance with its loan covenants calculated in accordance with applicable agreements as of March 31, 2023. The Company expects its cash flow from operations and its existing debt capacity can be used to meet anticipated future cash requirements for operations, capital expenditures, and dividend payments as well as potential acquisitions and stock repurchases. The Company’s contractual obligations consist primarily of operational commitments, which we expect to continue to be able to satisfy through cash generated from operations and debt. The Company has various series of notes outstanding that mature from 2023 through 2027. The Company believes that it has the ability to refinance or repay these obligations through a combination of cash flow from operations, issuance of additional notes, and sufficient borrowing capacity under the Company’s revolving credit facility, which matures in 2026.

13
Index
As a result of our ability to manage the impact of inflation through pricing and other actions, the impact of inflation was not material to the Company’s financial position and its results of operations for the three months ended March 31, 2023. The Company has experienced increased costs for certain inputs, such as raw materials, shipping and logistics, and labor-related costs. We continue to expect to manage these impacts in the near term, but persistent, accelerated, or expanded inflationary conditions could exacerbate these challenges and impact our profitability.

Cash Flows from Operating Activities
Net cash used in operating activities was $3.0 million and $0.9 million for the three months ended March 31, 2023 and 2022, respectively.

Cash Flows from Investing Activities
Net cash used in investing activities was $22.9 million and $12.2 million during the three months ended March 31, 2023 and 2022, respectively. Capital expenditures were $22.3 million and $12.7 million during the three months ended March 31, 2023 and 2022, respectively.

Cash Flows from Financing Activities
Net cash provided by financing activities was $24.6 million and $14.9 million for the three months ended March 31, 2023 and 2022, respectively. Net debt increased by $49.5 million and $33.8 million for the three months ended March 31, 2023 and 2022, respectively. The cash proceeds from the increase in net debt in the current period were primarily used to support capital expenditure investments during the three months ended March 31, 2023. For purposes of the cash flow statement, net changes in debt exclude the impact of foreign exchange rates. Dividends of $17.3 million and $17.2 million were paid during the three months ended March 31, 2023 and 2022, respectively. Dividends paid per share were $0.41 for both the three months ended March 31, 2023 and 2022.

CRITICAL ACCOUNTING POLICIES

There have been no material changes in the Company’s critical accounting policies during the quarter ended March 31, 2023. For additional information about the Company’s critical accounting policies, refer to “Critical Accounting Policies” under Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in the Company’s exposure to market risk during the quarter ended March 31, 2023. For additional information about market risk, refer to Part II, Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 4.
CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures: The Company carried out an evaluation, under the supervision and with the participation of management, including the Company’s Chairman, President, and Chief Executive Officer and its Senior Vice President and Chief Financial Officer, of the effectiveness, as of the end of the period covered by this report, of the design and operation of the disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based upon that evaluation, the Company’s Chairman, President, and Chief Executive Officer and its Senior Vice President and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting: There have been no changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the quarter ended March 31, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

14
Index
PART II.   OTHER INFORMATION

ITEM 1.
LEGAL PROCEEDINGS

See Part I, Item 1, Note 11, Commitments and Contingencies, of this report for information regarding legal proceedings in which the Company is involved.

ITEM 1A.
RISK FACTORS

There were no material changes to the risk factors previously disclosed in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On October 19, 2017, the Board of Directors authorized the repurchase of up to three million shares (2017 Authorization). As of March 31, 2023, 1,267,019 shares had been repurchased under the 2017 Authorization. There is no expiration date for the 2017 Authorization. The 2017 Authorization may be modified, suspended, or discontinued by the Board of Directors at any time. As of March 31, 2023, the maximum number of shares that may be purchased under publicly announced plans is 1,732,981. No shares were purchased by the Company during the three months ended March 31, 2023.

ITEM 6.
EXHIBITS

The exhibits listed in the following Exhibit Index are filed as part of this Quarterly Report on Form 10-Q.

15
Index
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2023

Exhibit
Description
Incorporated by Reference From
Filed Herewith
       
3.1
Amended and Restated By-Laws of Sensient Technologies Corporation, dated February 9, 2023
Exhibit 3.1 to Current Report on
Form 8-K filed February 14, 2023
(Commission File No. 1-7626)
  
       
31
Certifications of the Company’s Chairman, President & Chief Executive Officer and Senior Vice President & Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act
    X
       
Certifications of the Company’s Chairman, President & Chief Executive Officer and Senior Vice President & Chief Financial Officer pursuant to 18 United States Code § 1350
  
X
       
101.INS
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
  
X
       
101.SCH
Inline XBRL Taxonomy Extension Schema Document
  
X
       
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
  
X
       
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
  
X

101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
  
X
       
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
  
X
       
104
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
  
X

16
Index
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
 
SENSIENT TECHNOLOGIES CORPORATION
 
 
 
 
Date:
May 2, 2023
By:
/s/  John J. Manning
  
 
 
 
John J. Manning, Senior Vice
President, General Counsel &
Secretary
 
 
 
 
 

Date:
May 2, 2023
By:
/s/  Stephen J. Rolfs
  
 
 
 
Stephen J. Rolfs, Senior Vice
President & Chief Financial Officer
 


17